The Observation of Clinical Effects of Ganglioside in Patients with Acute Cerebral Infarction

Objective:Evaluation of Gangliosides(GM1) in the treatment of acute cerebral infarction clinical efficacy.Methods:64 cases of acute cerebral infarction were randomly divided into treatment group and control group,In giving the same routine treatment,The treatment group was added with Ganglioside(GM1 60 mg/d) dissolved in physiological saline(250 ml/d) in intravenous infusion for 14 days.In two groups were observed before and after treatment in patients with neurologic impairment score changes.Results:Ganglioside(GM1) treatment group after treatment of neural function defect score compared with the control group,there were significant differences(P0.05),the treatment group clinical curative effect obviously surpasses the comparison group(P0.05),the neurological function score improved significantly.Conclusion: Ganglioside(GM1) is applied to the early stage of acute cerebral infarction therapy can get good treatment effect.